The Recall Desk
ModerateFDA (Drugs)·D-0088-2021·Announced 2020-11-25

Milbar Recalls Malin + Goetz Dandruff Shampoo Due to GMP Deviations

Milbar Laboratories is recalling 5,312 bottles of Malin + Goetz dandruff shampoo due to Good Manufacturing Practice deviations.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and is voluntary, initiated due to GMP deviations without reported illnesses or injuries, fitting the criteria for a moderate severity precautionary recall.

Plain-English summary

Milbar Laboratories, Inc. is voluntarily recalling 5,312 bottles of (Malin + Goetz) dandruff Shampoo Psoriasis and Sebborrheic Dermatitis (1.9% Pyrithione Zinc) 8 fl.oz bottles. The recall was initiated by the firm on October 9, 2020, and was classified as Class II by the FDA. The reason for the recall is Good Manufacturing Practice (GMP) deviations.

The affected product is distributed by Malin+Goetz Inc. in New York, New York. The specific lots involved are GW905-5 (Expiration Date Jul-22) and KV428-3 (Expiration Date Oct-21). The product was distributed throughout the United States, including Puerto Rico, and internationally.

Consumers should stop using the affected product and return it to the place of purchase for a refund or follow instructions provided by the recalling firm. The recall status is currently terminated.

The recalled product

Product
(Malin + Goetz) dandruff Shampoo Psoriasis and Sebborrheic Dermatitis (1.9% Pyrithione Zinc) 8 fl.oz bottle, Distributed by: Malin+Goetz Inc 330 Seventh Avenue, New York, New York, 10001
Manufacturer
Milbar Laboratories, Inc.
Category
Drug — Topical Shampoo
Hazard
Affected units
5,312

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot #: GW905-5
  • Exp. Date Jul-22 Lot #: KV428-3
  • Exp. Date Oct-21

Distribution

Distributed in 1 state:

Part of a larger recall action

This product is one of 14 recalled by Milbar Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 14 products in this recall →

Related recalls

Same manufacturer · Milbar Laboratories, Inc.

See all →

Same hazard · gmp deviation

See all →